Top Highlights for February 2015: (Please click on read more to see details)
- Indian Medical Devices Industry to be $30 bn (INR 186,870 Crore) in next 10 years: AdvaMed Read more
- Mylan to acquire India based Famy Care’s Women Health business for about $800 mn (INR 4980 Crore) Read more
- Cipla wins $188.95 mn (INR 1176 Crore) of South Africa aids drug tender Read more
- Cipla inks 40:60 joint venture agreement with Algeria's Biopharm SPA Read more
- Cipla to invest upto $15 mn (INR 90 Crore) in JV with Cooper Pharma and PHI Read more
- Lupin, Celon Pharma announce agreement to jointly develop generic version of GlaxoSmithKline’s Advair Diskus
- Signet Chemical Corporation Pvt. Ltd partners with Belgium's Galactic Read more
- TPG invests $146 mn (INR 909 Crore) in Manipal Health for a significant minority stake Read more
- Intas launched their first biosimilar, Filgrastim, in Europe Read more
For more such news and updates on Global Life Science Business in India please join our Group on LinkedIn by the same name.
Aagami Updates: (Please click on hyperlink to view details)
- Aagami's latest Company Presentation and Case Studies are available on its company website.
- A Note on Mental Health (Especially Depression) in India (with some stats) Read more
- A compilation of select acquisitions made by Indian Lifesciences companies Read more